Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_provenance.
- NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_assertion description "[Since anti-PLGF was recently applied in clinical trials to inhibit cancer-related angiogenesis, here our data further demonstrate that inhibition of cancer neovascularization by anti-PLGF is mediated not only by direct effect on endothelial growth and capillary permeability, but also by indirect effect via MMP3 on the extracellular matrix degradation in larynx carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_provenance.
- NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_assertion evidence source_evidence_literature NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_provenance.
- NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_assertion SIO_000772 24946722 NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_provenance.
- NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_assertion wasDerivedFrom befree-20150227 NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_provenance.
- NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_assertion wasGeneratedBy ECO_0000203 NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP617103.RASRkMr-15lbxfKqrpXNMfnvWdKlLeJzo5uno4Vg53c-0130_provenance.